1Diaz Cascajo C,Weyers W,Borrego L,et al.Dermatofibrosarcoma Protuberans with fibrosarcomatous areas:a clinicopathologic and immunohistochemic study in four cases[J].Am J Dermatopathol,1997,19(6):562-567.
2West RB,Harvell J,Linn SC,et al.Apo D in Soft Tissue Tumors:A Novel Marker for Dermatofibrosarcoma Rrotuberans[J].Am J Surg Pathol,2004,28(8):1063-1069.
2[2]Calonje E,Fletcher CDM. Myxoid differentiation in dermatofibrosarcoma protuberans and its fibrosarcomatous variant:clinicopathologic analysis of 5 cases.J Cutan Pathol,1996,23:30～6.
3[3]Connelly JH,Evans HL. Dermatofibrosarcoma protuberans. A clinicopathological review with emphasis on fibrosarcomatous areas. Am J Surg Pathol,1992,16:921.
4[4]Betti R,Inselvini E,Crosti C. Unusal features of primary dermatofibrosarcoma protuberans and its myxoid recurrence. J Cutan Pathol,1996,23:283～7.
5[5]Frierson HF,Cooper PH.Myxoid variant of dermatofibrosarcoma protuberans.Am J Surg Pathol,1983,7:445.
6[7]Shmookler BM,Enzinger FM,Weiss SW. Giant cell fibroblastoma. A juvenile form of dermatofibrosarcoma protuberans. Cancer,1989,64:2154.
7[8]Cin PD,Sciot R,Wever ID,et al.Cytogenetic and immunohistochemical evidence that giant cell fibroblastoma is related to dermatofibrosarcoma protuberans.Genes Chrom Cancer,1996,15:73.
8[9]Zelger B,Sidoroff A,Stanzl U,et al. Deep penetrating dermatofibroma versus dermatofibrosarcoma protuberans. Am J Surg Pathol, 1994,18:677～86.
9[11]Rudolph P, Schubert B,Wacker HH, et al. Immunophenotyping of dermal spindle cell tumors:Diagnostic value of monocyte marker Ki-M1P and histogenetic considerations.Am J Surg Pathol,1997,21(7):791～800.
10[12]Lothe RA,Karbu R,Mandahl N,et al.Gain of 17q24-qter detected by comparative genomic hybridization in malignant tumors from patients with von Recklinghausen's NF. Cancer Res,1996,56(20):4778.
